Drooid Logo
Back to story perspectives

Full Breakdown

Nicotine E-Cigarettes Prove Most Effective Smoking-Cessation Tool in Major Review

8/26/2026, 7:47:58 PM

Core Findings of the Cochrane Review

  • An updated “living” systematic review examined 80 randomized controlled trials involving 29,861 adult smokers.
  • High-certainty evidence shows nicotine-containing e-cigarettes produced about four additional quitters per 100 people compared with nicotine-replacement therapy and two additional quitters per 100 compared with non-nicotine vaping.
  • The overall quit rate rose from roughly six per 100 to ten per 100, a relative increase of about 60 %.
  • No increase in serious adverse events was detected; the analysis applies only to regulated nicotine e-cigarettes.

Background & Context

  • Smoking kills over seven million people each year, and traditional cessation aids achieve modest success.
  • In the United Kingdom, adult vaping now exceeds smoking, with 5.4 million adults using e-cigarettes versus 5.3 million smokers.
  • The NHS has begun offering regulated e-cigarettes through its stop-smoking services.

Data & Statistics

  • Trials analyzed: 80
  • Participants: 29,861
  • Quit-rate improvement vs. NRT: +4 per 100 (?67 % relative increase)
  • Quit-rate improvement vs. non-nicotine vaping: +2 per 100
  • Adult prevalence (UK): 5.4 million vapers (?10 % of adults) vs. 5.3 million smokers

Official Statements & Responses

  • Dr Jamie Hartmann-Boyce, senior author of the review, says regulated nicotine e-cigarettes are “substantially less harmful than smoking” and a “proven and viable option” for cessation.
  • The NHS now lists e-cigarettes alongside patches, gum, and prescription medicines as standard cessation tools.
  • Regulatory agencies such as the UK MHRA and the US FDA maintain public lists of approved devices and urge users to select only those that meet safety standards.

Conflicting Reports & Gaps

  • The Cochrane review tracked participants for up to two years; longer-term safety data remain lacking.
  • A *Nature Medicine* study reported higher lung-cancer incidence among former smokers who switched to vaping, a finding not addressed by the Cochrane analysis.
  • The review did not investigate dependence on e-cigarettes or strategies for quitting vaping after smoking cessation.

Verbatim Quotes

  • “We have very strong evidence that regulated nicotine e-cigarettes are substantially less harmful than smoking,” — Dr Jamie Hartmann-Boyce
  • “ Dr McKean added: "It must not be seen as a one-and-done solution.” — Dr Mike McKean

What’s Next

  • The United Kingdom’s ban on selling any vape or nicotine product to individuals under 18 will take effect on October 29.
  • The Cochrane “living” review will continue to incorporate new trial data, aiming to clarify long-term health outcomes and inform future public-health recommendations.